Literature DB >> 25343063

Intractable and rare diseases research.

Wei Tang1, Masatoshi Makuuchi2.   

Abstract

Year:  2012        PMID： 25343063      PMCID： PMC4204594          DOI： 10.5582/irdr.2012.v1.1.1

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN： 2186-3644


× No keyword cloud information.
  2 in total

Review 1.  Rare diseases, orphan drugs and their regulation: questions and misconceptions.

Authors:  Erik Tambuyzer
Journal:  Nat Rev Drug Discov       Date:  2010-11-09       Impact factor: 84.694

2.  The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?

Authors:  Olivier Wellman-Labadie; Youwen Zhou
Journal:  Health Policy       Date:  2009-12-29       Impact factor: 2.980
  2 in total
  5 in total

1.  Research on economy and social exclusion: China dolls and rare diseases.

Authors:  Akihiko Matsui
Journal:  Intractable Rare Dis Res       Date:  2013-02

Review 2.  Access to orphan drugs in the Middle East: Challenge and perspective.

Authors:  Ziyad S Almalki; Abdullah K Alahmari; Jeff J Guo; Christina M L Kelton
Journal:  Intractable Rare Dis Res       Date:  2012-11

Review 3.  Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.

Authors:  Lin Mei; Peipei Song; Norihiro Kokudo; Lingzhong Xu; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2013-11

Review 4.  Innovative measures to combat rare diseases in China: The national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research.

Authors:  Peipei Song; Jiangjiang He; Fen Li; Chunlin Jin
Journal:  Intractable Rare Dis Res       Date:  2017-02

5.  Statistical resolutions for large variabilities in hair mineral analysis.

Authors:  Tsuyoshi Nakamura; Tomomi Yamada; Koshi Kataoka; Koichiro Sera; Todd Saunders; Toshihiro Takatsuji; Toshio Makie; Yoshiaki Nose
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.